Search

Search Results

• 

  Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

  Marco P. Donadini, Walter Ageno

  15-04-2022

  https://doi.org/10.4081/btvb.2022.22

  2039

  PDF: 542
• 

  Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

  Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato

  21-03-2023

  https://doi.org/10.4081/btvb.2023.59

  580

  PDF: 231
• 

  A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

  Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

  23-05-2022

  https://doi.org/10.4081/btvb.2022.19

  4678

  PDF: 281
• 

  Antithrombotic therapy in idiopathic infertility

  Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

  03-10-2024

  https://doi.org/10.4081/btvb.2024.126

  1996

  PDF: 493
• 

  How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

  Anna Falanga, Hugo Ten Cate, Bianca Rocca

  27-01-2023

  https://doi.org/10.4081/btvb.2023.60

  694

  PDF: 311
• 

  The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective

  Augusto Di Castelnuovo

  01-07-2025

  https://doi.org/10.4081/btvb.2025.184

  328

  PDF: 105
• 

  2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology

  Bianca Rocca, Emma Hansson, Milan Milojevic, Anders Jeppsson

  01-07-2025

  https://doi.org/10.4081/btvb.2025.178

  555

  PDF: 148
• 

  The balance between hemorrhage and thrombosis in patients surviving spontaneous intracerebral bleeding: the nightmare of a neurologist

  Alessandro Pezzini

  21-08-2024

  https://doi.org/10.4081/btvb.2024.151

  1316

  PDF: 359
• 

  Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

  Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

  22-03-2022

  https://doi.org/10.4081/btvb.2022.10

  1100

  PDF: 354

  APPENDIX: 73
• 

  Distal deep vein thrombosis: is there a way out of this dark forest?

  Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini

  04-09-2024

  https://doi.org/10.4081/btvb.2024.129

  787

  PDF: 261
• 

  Blood platelets, prostaglandins and aspirin: a historical and personal rereading

  Giovanni de Gaetano, Chiara Cerletti

  13-03-2024

  https://doi.org/10.4081/btvb.2024.121

  1295

  PDF: 224
• 

  The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action

  Martina Berteotti, Walter Ageno, Rossella Marcucci, Andrea Stella, Paolo Zamboni, Romeo Martini

  30-06-2025

  https://doi.org/10.4081/btvb.2025.164

  287

  PDF: 93